|
Publication
|
Title of Article |
Buparlisib and ponatinib inhibit aggressiveness of cholangiocarcinoma cells via suppression of IRS1-related pathway by targeting oxidative stress resistance |
Date of Acceptance |
9 October 2024 |
Journal |
Title of Journal |
Biomedicine & Pharmacotherapy |
Standard |
SCOPUS Tier 1 |
Institute of Journal |
ELSEVIER |
ISBN/ISSN |
|
Volume |
2024 |
Issue |
180 |
Month |
|
Year of Publication |
2024 |
Page |
117569 |
Abstract |
|
Keyword |
Bile duct cancer, Targeted therapy, Buparlisib, Ponatinib, Anti-cancer, Insulin receptor substrate 1 |
Author |
|
Reviewing Status |
มีผู้ประเมินอิสระ |
Status |
ตีพิมพ์แล้ว |
Level of Publication |
นานาชาติ |
citation |
true |
Part of thesis |
true |
ใช้สำหรับสำเร็จการศึกษา |
ไม่เป็น |
Attach file |
|
Citation |
0
|
|
|
|
|
|
|